{"transactions":[{"id":1418112,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-09-03T21:06:12.000Z","date":"2024-08-30","kind":"grant","planned":false,"acquired":true,"shares":51039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Inducement grant comprised of stock options to purchase shares of common stock subject to time lapse vesting. 25% of the stock options vest on the 1-year anniversary of the grant date and the remaining 75% of the stock options vest in equal monthly installments over the subsequent 3 years to the 1-year anniversary of the grant date, with each installment vesting subject to the grantee's continued employment with the company."}],"balance_after":51039,"derivative":{"exercise_price":57.08,"exercise_date":"2025-09-01","expiration_date":"2034-08-30","underlying":"Common Stock","underlying_shares":51039},"source":{"system":"sec-edgar","filing":"0001127602-24-023331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224023331/form4.xml","form_type":"4"}},{"id":1418111,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-09-03T21:06:12.000Z","date":"2024-08-30","kind":"grant","planned":false,"acquired":true,"shares":33140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Inducement grant comprised of restricted stock units (\"RSUs\") that are converted into shares of common stock on a 1:1 basis upon time based vesting. 40% of the RSUs vest on the 1-year anniversary of the grant date, an additional 40% of the RSUs vest on the 2-year anniversary of the grant date, and the remaining 20% of the RSUs vest on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment with the company."}],"balance_after":33140,"source":{"system":"sec-edgar","filing":"0001127602-24-023331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224023331/form4.xml","form_type":"4"}},{"id":360416,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2022-06-14T00:01:37.000Z","date":"2022-06-10","kind":"exercise","acquired":false,"shares":782,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":16519,"derivative":{"underlying":"Common Stock","underlying_shares":782},"source":{"system":"sec-edgar","filing":"0001127602-22-017328","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017328/form4.xml","form_type":"4"}},{"id":360415,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-06-14T00:01:37.000Z","date":"2022-06-10","kind":"tax_withholding","acquired":false,"shares":280,"price":60.74,"value":17007.2,"ownership":{"direct":true},"balance_after":33426,"source":{"system":"sec-edgar","filing":"0001127602-22-017328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017328/form4.xml","form_type":"4"}},{"id":360414,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-06-14T00:01:37.000Z","date":"2022-06-10","kind":"exercise","acquired":true,"shares":782,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":33706,"source":{"system":"sec-edgar","filing":"0001127602-22-017328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017328/form4.xml","form_type":"4"}},{"id":362704,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-04-14T00:34:54.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":348,"price":52.1305,"value":18141.414,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of August 16, 2021\nthrough February 15, 2022. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on February 15, 2022."}],"balance_after":32924,"source":{"system":"sec-edgar","filing":"0001127602-22-011955","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222011955/form4.xml","form_type":"4"}},{"id":363927,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2022-03-15T01:46:01.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":3130,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":17301,"derivative":{"underlying":"Common Stock","underlying_shares":3130},"source":{"system":"sec-edgar","filing":"0001127602-22-009215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009215/form4.xml","form_type":"4"}},{"id":363926,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2022-03-15T01:46:01.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":2593,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":20431,"derivative":{"underlying":"Common Stock","underlying_shares":2593},"source":{"system":"sec-edgar","filing":"0001127602-22-009215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009215/form4.xml","form_type":"4"}},{"id":363925,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T01:46:01.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":3634,"price":58.24,"value":211644.16,"ownership":{"direct":true},"balance_after":32576,"source":{"system":"sec-edgar","filing":"0001127602-22-009215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009215/form4.xml","form_type":"4"}},{"id":363924,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T01:46:01.000Z","date":"2022-03-10","kind":"tax_withholding","acquired":false,"shares":2089,"price":57.92,"value":120994.88,"ownership":{"direct":true},"balance_after":36210,"source":{"system":"sec-edgar","filing":"0001127602-22-009215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009215/form4.xml","form_type":"4"}},{"id":363923,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T01:46:01.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":3130,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":38299,"source":{"system":"sec-edgar","filing":"0001127602-22-009215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009215/form4.xml","form_type":"4"}},{"id":363922,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-03-15T01:46:01.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":2593,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":35169,"source":{"system":"sec-edgar","filing":"0001127602-22-009215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009215/form4.xml","form_type":"4"}},{"id":366129,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-02-11T19:57:34.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":1691,"price":63.89,"value":108037.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":32576,"source":{"system":"sec-edgar","filing":"0001127602-22-004516","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222004516/form4.xml","form_type":"4"}},{"id":366372,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2022-02-09T01:24:10.000Z","date":"2022-02-06","kind":"exercise","acquired":false,"shares":2727,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":23024,"derivative":{"underlying":"Common Stock","underlying_shares":2727},"source":{"system":"sec-edgar","filing":"0001127602-22-003846","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222003846/form4.xml","form_type":"4"}},{"id":366371,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-02-09T01:24:10.000Z","date":"2022-02-06","kind":"tax_withholding","acquired":false,"shares":1036,"price":63.9,"value":66200.4,"ownership":{"direct":true},"balance_after":34267,"source":{"system":"sec-edgar","filing":"0001127602-22-003846","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222003846/form4.xml","form_type":"4"}},{"id":366370,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-02-09T01:24:10.000Z","date":"2022-02-06","kind":"exercise","acquired":true,"shares":2727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":35303,"source":{"system":"sec-edgar","filing":"0001127602-22-003846","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222003846/form4.xml","form_type":"4"}},{"id":366823,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-02-02T23:37:34.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":14061,"price":68.5358,"value":963681.8838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan dated May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transaction reported here range from $68.34 to $68.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners\nupon request."}],"balance_after":32576,"source":{"system":"sec-edgar","filing":"0001127602-22-003048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222003048/form4.xml","form_type":"4"}},{"id":367086,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-01-29T01:41:58.000Z","date":"2022-01-26","kind":"tax_withholding","acquired":false,"shares":5681,"price":67.34,"value":382558.54,"ownership":{"direct":true},"balance_after":46637,"source":{"system":"sec-edgar","filing":"0001127602-22-002462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222002462/form4.xml","form_type":"4"}},{"id":367085,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-01-29T01:41:58.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":19742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 6, 2019. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":52318,"source":{"system":"sec-edgar","filing":"0001127602-22-002462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222002462/form4.xml","form_type":"4"}},{"id":367084,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2022-01-29T01:41:58.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":15262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2020, and March 10, 2021. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":32576,"source":{"system":"sec-edgar","filing":"0001127602-22-002462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222002462/form4.xml","form_type":"4"}},{"id":372117,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-08-24T22:15:22.000Z","date":"2021-08-15","kind":"grant","acquired":true,"shares":32,"price":55.08,"value":1762.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of February 16, 2021 through August 15, 2021. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on February 16, 2021."}],"balance_after":29198,"source":{"system":"sec-edgar","filing":"0001127602-21-024266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221024266/form4.xml","form_type":"4"}},{"id":377945,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-03-12T23:39:47.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":72855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":72855,"derivative":{"exercise_price":63.91,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":72855},"source":{"system":"sec-edgar","filing":"0001127602-21-010474","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010474/form4.xml","form_type":"4"}},{"id":377944,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T23:39:47.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":12520,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units have a four-year vesting schedule.  25% vest on the first anniversary of the date of the grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":25751,"derivative":{"underlying":"Common Stock","underlying_shares":12520},"source":{"system":"sec-edgar","filing":"0001127602-21-010474","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010474/form4.xml","form_type":"4"}},{"id":377943,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T23:39:47.000Z","date":"2021-03-10","kind":"exercise","acquired":false,"shares":2593,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":13231,"derivative":{"underlying":"Common Stock","underlying_shares":2593},"source":{"system":"sec-edgar","filing":"0001127602-21-010474","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010474/form4.xml","form_type":"4"}},{"id":377942,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-03-12T23:39:47.000Z","date":"2021-03-11","kind":"sale","acquired":false,"shares":1486,"price":63.36,"value":94152.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan"}],"balance_after":29166,"source":{"system":"sec-edgar","filing":"0001127602-21-010474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010474/form4.xml","form_type":"4"}},{"id":377941,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-03-12T23:39:47.000Z","date":"2021-03-10","kind":"tax_withholding","acquired":false,"shares":1107,"price":63.91,"value":70748.37,"ownership":{"direct":true},"balance_after":30652,"source":{"system":"sec-edgar","filing":"0001127602-21-010474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010474/form4.xml","form_type":"4"}},{"id":377940,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-03-12T23:39:47.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":2593,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":31759,"source":{"system":"sec-edgar","filing":"0001127602-21-010474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010474/form4.xml","form_type":"4"}},{"id":377939,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-03-12T23:39:47.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":334,"price":56.8565,"value":18990.071,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of August 16, 2020\nthrough February 15, 2021. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on February 15, 2021."}],"balance_after":29166,"source":{"system":"sec-edgar","filing":"0001127602-21-010474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010474/form4.xml","form_type":"4"}},{"id":380552,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-02-11T22:56:00.000Z","date":"2021-02-10","kind":"sale","acquired":false,"shares":1975,"price":67.41,"value":133134.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan"}],"balance_after":28832,"source":{"system":"sec-edgar","filing":"0001127602-21-005277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221005277/form4.xml","form_type":"4"}},{"id":380673,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2021-02-10T00:44:17.000Z","date":"2021-02-06","kind":"exercise","acquired":false,"shares":2728,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":15824,"derivative":{"underlying":"Common Stock","underlying_shares":2728},"source":{"system":"sec-edgar","filing":"0001127602-21-004790","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221004790/form4.xml","form_type":"4"}},{"id":380672,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-02-10T00:44:17.000Z","date":"2021-02-06","kind":"tax_withholding","acquired":false,"shares":753,"price":68.46,"value":51550.38,"ownership":{"direct":true},"balance_after":30807,"source":{"system":"sec-edgar","filing":"0001127602-21-004790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221004790/form4.xml","form_type":"4"}},{"id":380671,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-02-10T00:44:17.000Z","date":"2021-02-06","kind":"exercise","acquired":true,"shares":2728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":31560,"source":{"system":"sec-edgar","filing":"0001127602-21-004790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221004790/form4.xml","form_type":"4"}},{"id":381015,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-02-03T23:23:59.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":9711,"price":65.9698,"value":640632.7278,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transaction reported here range from $65.73 to $66.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":28832,"source":{"system":"sec-edgar","filing":"0001127602-21-003820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221003820/form4.xml","form_type":"4"}},{"id":381263,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-01-29T01:08:18.000Z","date":"2021-01-26","kind":"tax_withholding","acquired":false,"shares":3736,"price":66.7,"value":249191.2,"ownership":{"direct":true},"balance_after":38543,"source":{"system":"sec-edgar","filing":"0001127602-21-002920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221002920/form4.xml","form_type":"4"}},{"id":381262,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-01-29T01:08:18.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":13447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2018. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":42279,"source":{"system":"sec-edgar","filing":"0001127602-21-002920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221002920/form4.xml","form_type":"4"}},{"id":381261,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2021-01-29T01:08:18.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":14188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":28832,"source":{"system":"sec-edgar","filing":"0001127602-21-002920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221002920/form4.xml","form_type":"4"}},{"id":391056,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-05-07T22:02:03.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001127602-20-015824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015824/form4.xml","form_type":"4"}},{"id":391055,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-05-07T22:02:03.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":12560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":12560},"source":{"system":"sec-edgar","filing":"0001127602-20-015824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015824/form4.xml","form_type":"4"}},{"id":391054,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-05-07T22:02:03.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":13210,"price":79.2309,"value":1046640.189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $79.23 to $79.24.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":14644,"source":{"system":"sec-edgar","filing":"0001127602-20-015824","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015824/form4.xml","form_type":"4"}},{"id":391053,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-05-07T22:02:03.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":650,"price":24.295,"value":15791.75,"ownership":{"direct":true},"balance_after":27854,"source":{"system":"sec-edgar","filing":"0001127602-20-015824","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015824/form4.xml","form_type":"4"}},{"id":391052,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-05-07T22:02:03.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":12560,"price":40.56,"value":509433.6,"ownership":{"direct":true},"balance_after":27204,"source":{"system":"sec-edgar","filing":"0001127602-20-015824","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015824/form4.xml","form_type":"4"}},{"id":393169,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2020-03-13T00:30:33.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":10370,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":18552,"derivative":{"underlying":"Common Stock","underlying_shares":10370},"source":{"system":"sec-edgar","filing":"0001127602-20-010517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010517/form4.xml","form_type":"4"}},{"id":393168,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-03-13T00:30:33.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":61590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":61590,"derivative":{"exercise_price":72.34,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":61590},"source":{"system":"sec-edgar","filing":"0001127602-20-010517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010517/form4.xml","form_type":"4"}},{"id":393167,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-03-13T00:30:33.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":2950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":650,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":2950},"source":{"system":"sec-edgar","filing":"0001127602-20-010517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010517/form4.xml","form_type":"4"}},{"id":393166,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-03-13T00:30:33.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":2950,"price":75.55,"value":222872.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":14644,"source":{"system":"sec-edgar","filing":"0001127602-20-010517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010517/form4.xml","form_type":"4"}},{"id":393165,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-03-13T00:30:33.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":2950,"price":24.295,"value":71670.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":17594,"source":{"system":"sec-edgar","filing":"0001127602-20-010517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010517/form4.xml","form_type":"4"}},{"id":393976,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-03-04T00:40:04.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":1100,"price":71.2573,"value":78383.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $71.22 to $71.33.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":14644,"source":{"system":"sec-edgar","filing":"0001127602-20-009244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220009244/form4.xml","form_type":"4"}},{"id":393975,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-03-04T00:40:04.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":9341,"price":70.8308,"value":661630.5028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $70.21 to $71.21.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":15744,"source":{"system":"sec-edgar","filing":"0001127602-20-009244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220009244/form4.xml","form_type":"4"}},{"id":393974,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-03-04T00:40:04.000Z","date":"2020-02-15","kind":"grant","acquired":true,"shares":395,"price":53.669,"value":21199.255,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of August 16, 2019\nthrough February 15, 2020. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on February 15, 2020."}],"balance_after":25085,"source":{"system":"sec-edgar","filing":"0001127602-20-009244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220009244/form4.xml","form_type":"4"}},{"id":395522,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-02-12T23:25:17.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":2950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":3600,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":2950},"source":{"system":"sec-edgar","filing":"0001127602-20-005129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220005129/form4.xml","form_type":"4"}},{"id":395521,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-02-12T23:25:17.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":2950,"price":69.32,"value":204494.0,"ownership":{"direct":true},"balance_after":24690,"source":{"system":"sec-edgar","filing":"0001127602-20-005129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220005129/form4.xml","form_type":"4"}},{"id":395520,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-02-12T23:25:17.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":2950,"price":24.295,"value":71670.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":27640,"source":{"system":"sec-edgar","filing":"0001127602-20-005129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220005129/form4.xml","form_type":"4"}},{"id":395664,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Restricted Stock Unit","published_at":"2020-02-11T00:00:37.000Z","date":"2020-02-06","kind":"exercise","acquired":false,"shares":2728,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":8182,"derivative":{"underlying":"Common Stock","underlying_shares":2728},"source":{"system":"sec-edgar","filing":"0001127602-20-004716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004716/form4.xml","form_type":"4"}},{"id":395663,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-02-11T00:00:37.000Z","date":"2020-02-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":12560,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-20-004716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004716/form4.xml","form_type":"4"}},{"id":395662,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-02-11T00:00:37.000Z","date":"2020-02-07","kind":"sale","acquired":false,"shares":1426,"price":70,"value":99820.0,"ownership":{"direct":true},"balance_after":24690,"source":{"system":"sec-edgar","filing":"0001127602-20-004716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004716/form4.xml","form_type":"4"}},{"id":395661,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-02-11T00:00:37.000Z","date":"2020-02-06","kind":"tax_withholding","acquired":false,"shares":1302,"price":68.21,"value":88809.42,"ownership":{"direct":true},"balance_after":26116,"source":{"system":"sec-edgar","filing":"0001127602-20-004716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004716/form4.xml","form_type":"4"}},{"id":395660,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-02-11T00:00:37.000Z","date":"2020-02-06","kind":"exercise","acquired":true,"shares":2728,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":27418,"source":{"system":"sec-edgar","filing":"0001127602-20-004716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004716/form4.xml","form_type":"4"}},{"id":395659,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-02-11T00:00:37.000Z","date":"2020-02-06","kind":"sale","acquired":false,"shares":5000,"price":68.1801,"value":340900.5,"ownership":{"direct":true},"balance_after":24690,"source":{"system":"sec-edgar","filing":"0001127602-20-004716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004716/form4.xml","form_type":"4"}},{"id":395658,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-02-11T00:00:37.000Z","date":"2020-02-06","kind":"exercise","acquired":true,"shares":5000,"price":40.56,"value":202800.0,"ownership":{"direct":true},"balance_after":29690,"source":{"system":"sec-edgar","filing":"0001127602-20-004716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004716/form4.xml","form_type":"4"}},{"id":396389,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-01-31T23:23:11.000Z","date":"2020-01-29","kind":"tax_withholding","acquired":false,"shares":4587,"price":64.3,"value":294944.1,"ownership":{"direct":true},"balance_after":24690,"source":{"system":"sec-edgar","filing":"0001127602-20-002965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220002965/form4.xml","form_type":"4"}},{"id":396388,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-01-31T23:23:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":4126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 2, 2017. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":29277,"source":{"system":"sec-edgar","filing":"0001127602-20-002965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220002965/form4.xml","form_type":"4"}},{"id":396387,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-01-31T23:23:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":8087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2018, and February 6, 2019. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":25151,"source":{"system":"sec-edgar","filing":"0001127602-20-002965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220002965/form4.xml","form_type":"4"}},{"id":397114,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-01-07T00:01:07.000Z","date":"2020-01-03","kind":"exercise","acquired":false,"shares":2950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":6550,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":2950},"source":{"system":"sec-edgar","filing":"0001127602-20-001254","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220001254/form4.xml","form_type":"4"}},{"id":397113,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-01-07T00:01:07.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":2950,"price":64.63,"value":190658.5,"ownership":{"direct":true},"balance_after":17064,"source":{"system":"sec-edgar","filing":"0001127602-20-001254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220001254/form4.xml","form_type":"4"}},{"id":397112,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2020-01-07T00:01:07.000Z","date":"2020-01-03","kind":"exercise","acquired":true,"shares":2950,"price":24.295,"value":71670.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20014,"source":{"system":"sec-edgar","filing":"0001127602-20-001254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220001254/form4.xml","form_type":"4"}},{"id":398292,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-12-05T00:11:11.000Z","date":"2019-12-03","kind":"exercise","acquired":false,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":9500,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":5900},"source":{"system":"sec-edgar","filing":"0001127602-19-034297","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219034297/form4.xml","form_type":"4"}},{"id":398291,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-12-05T00:11:11.000Z","date":"2019-12-03","kind":"sale","acquired":false,"shares":5900,"price":65.77,"value":388043.0,"ownership":{"direct":true},"balance_after":17064,"source":{"system":"sec-edgar","filing":"0001127602-19-034297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219034297/form4.xml","form_type":"4"}},{"id":398290,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-12-05T00:11:11.000Z","date":"2019-12-03","kind":"exercise","acquired":true,"shares":5900,"price":24.295,"value":143340.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":22964,"source":{"system":"sec-edgar","filing":"0001127602-19-034297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219034297/form4.xml","form_type":"4"}},{"id":398626,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-11-26T19:14:25.000Z","date":"2019-11-25","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":17560,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-19-033740","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033740/form4.xml","form_type":"4"}},{"id":398625,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-26T19:14:25.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":15000,"price":66.8539,"value":1002808.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale prices reported for the transactions reported here range from $66.85 to $66.88.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":17064,"source":{"system":"sec-edgar","filing":"0001127602-19-033740","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033740/form4.xml","form_type":"4"}},{"id":398624,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-26T19:14:25.000Z","date":"2019-11-25","kind":"exercise","acquired":true,"shares":15000,"price":40.56,"value":608400.0,"ownership":{"direct":true},"balance_after":32064,"source":{"system":"sec-edgar","filing":"0001127602-19-033740","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033740/form4.xml","form_type":"4"}},{"id":398798,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-11-20T23:11:08.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":15400,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-19-033438","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033438/form4.xml","form_type":"4"}},{"id":398797,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-11-20T23:11:08.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":25400,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-19-033438","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033438/form4.xml","form_type":"4"}},{"id":398796,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-20T23:11:08.000Z","date":"2019-11-19","kind":"sale","acquired":false,"shares":10000,"price":64.9062,"value":649062.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $64.90 to $64.93.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":17064,"source":{"system":"sec-edgar","filing":"0001127602-19-033438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033438/form4.xml","form_type":"4"}},{"id":398795,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-20T23:11:08.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":10000,"price":24.295,"value":242950.0,"ownership":{"direct":true},"balance_after":27064,"source":{"system":"sec-edgar","filing":"0001127602-19-033438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033438/form4.xml","form_type":"4"}},{"id":398794,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-20T23:11:08.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":10000,"price":63.85,"value":638500.0,"ownership":{"direct":true},"balance_after":17064,"source":{"system":"sec-edgar","filing":"0001127602-19-033438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033438/form4.xml","form_type":"4"}},{"id":398793,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-20T23:11:08.000Z","date":"2019-11-18","kind":"exercise","acquired":true,"shares":10000,"price":24.295,"value":242950.0,"ownership":{"direct":true},"balance_after":27064,"source":{"system":"sec-edgar","filing":"0001127602-19-033438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033438/form4.xml","form_type":"4"}},{"id":398792,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-20T23:11:08.000Z","date":"2019-11-14","kind":"gift","acquired":false,"shares":762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares gifted to charitable trust"}],"balance_after":17064,"source":{"system":"sec-edgar","filing":"0001127602-19-033438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219033438/form4.xml","form_type":"4"}},{"id":399182,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-08T01:04:46.000Z","date":"2019-11-05","kind":"sale","acquired":false,"shares":2095,"price":66.0638,"value":138403.661,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale prices reported for the transactions reported here range from $66.06 to $66.07.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":17826,"source":{"system":"sec-edgar","filing":"0001127602-19-032265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219032265/form4.xml","form_type":"4"}},{"id":399277,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-11-06T01:21:43.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a five-year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":16.89,"expiration_date":"2020-07-22","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001127602-19-031974","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219031974/form4.xml","form_type":"4"}},{"id":399276,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-06T01:21:43.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":4000,"price":64.5247,"value":258098.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $64.5201 to $64.53.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":19921,"source":{"system":"sec-edgar","filing":"0001127602-19-031974","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219031974/form4.xml","form_type":"4"}},{"id":399275,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP,Corp Affairs & Gen Counsel"}}],"security":"Common Stock","published_at":"2019-11-06T01:21:43.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":2400,"price":16.89,"value":40536.0,"ownership":{"direct":true},"balance_after":23921,"source":{"system":"sec-edgar","filing":"0001127602-19-031974","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219031974/form4.xml","form_type":"4"}},{"id":399443,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-10-31T00:35:01.000Z","date":"2019-10-28","kind":"sale","acquired":false,"shares":5677,"price":63.3102,"value":359412.0054,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale prices reported for the transactions reported here range from $63.31 to $63.3102.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":21521,"source":{"system":"sec-edgar","filing":"0001127602-19-031294","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219031294/form4.xml","form_type":"4"}},{"id":400760,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-08-20T19:13:00.000Z","date":"2019-08-19","kind":"sale","acquired":false,"shares":608,"price":64.3478,"value":39123.4624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale prices reported for the transactions reported here range from $64.3433 to $64.35.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":27198,"source":{"system":"sec-edgar","filing":"0001127602-19-027052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219027052/form4.xml","form_type":"4"}},{"id":400945,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2019-08-13T22:48:00.000Z","date":"2019-08-10","kind":"exercise","acquired":false,"shares":1070,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":10910,"derivative":{"underlying":"Common Stock","underlying_shares":1070},"source":{"system":"sec-edgar","filing":"0001127602-19-026569","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219026569/form4.xml","form_type":"4"}},{"id":400944,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-08-13T22:48:00.000Z","date":"2019-08-10","kind":"tax_withholding","acquired":false,"shares":462,"price":65.24,"value":30140.88,"ownership":{"direct":true},"balance_after":27806,"source":{"system":"sec-edgar","filing":"0001127602-19-026569","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219026569/form4.xml","form_type":"4"}},{"id":400943,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-08-13T22:48:00.000Z","date":"2019-08-10","kind":"exercise","acquired":true,"shares":1070,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":28268,"source":{"system":"sec-edgar","filing":"0001127602-19-026569","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219026569/form4.xml","form_type":"4"}},{"id":401311,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-07-25T22:37:28.000Z","date":"2019-07-23","kind":"exercise","acquired":false,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a five-year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0001127602-19-025217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219025217/form4.xml","form_type":"4"}},{"id":401310,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-07-25T22:37:28.000Z","date":"2019-07-23","kind":"sale","acquired":false,"shares":7200,"price":65.07,"value":468504.0,"ownership":{"direct":true},"balance_after":27198,"source":{"system":"sec-edgar","filing":"0001127602-19-025217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219025217/form4.xml","form_type":"4"}},{"id":401309,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-07-25T22:37:28.000Z","date":"2019-07-23","kind":"exercise","acquired":true,"shares":7200,"price":24.905,"value":179316.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":34398,"source":{"system":"sec-edgar","filing":"0001127602-19-025217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219025217/form4.xml","form_type":"4"}},{"id":401965,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-06-20T20:52:50.000Z","date":"2019-06-18","kind":"sale","acquired":false,"shares":5816,"price":68.75,"value":399850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":27198,"source":{"system":"sec-edgar","filing":"0001127602-19-022379","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219022379/form4.xml","form_type":"4"}},{"id":405467,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-03-14T20:31:15.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":330,"price":57.4515,"value":18958.995,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of August 16, 2018 through February, 15 2019. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on February 15, 2019."}],"balance_after":33014,"source":{"system":"sec-edgar","filing":"0001127602-19-011363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219011363/form4.xml","form_type":"4"}},{"id":408175,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2019-02-09T00:39:11.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":10910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":11980,"derivative":{"underlying":"Common Stock","underlying_shares":10910},"source":{"system":"sec-edgar","filing":"0001127602-19-004920","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004920/form4.xml","form_type":"4"}},{"id":408174,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-02-09T00:39:11.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":50480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":50480,"derivative":{"exercise_price":68.75,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":50480},"source":{"system":"sec-edgar","filing":"0001127602-19-004920","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004920/form4.xml","form_type":"4"}},{"id":408173,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-02-09T00:39:11.000Z","date":"2019-02-06","kind":"tax_withholding","acquired":false,"shares":3871,"price":68.75,"value":266131.25,"ownership":{"direct":true},"balance_after":32684,"source":{"system":"sec-edgar","filing":"0001127602-19-004920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004920/form4.xml","form_type":"4"}},{"id":408172,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-02-09T00:39:11.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":6463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":36555,"source":{"system":"sec-edgar","filing":"0001127602-19-004920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004920/form4.xml","form_type":"4"}},{"id":408171,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2019-02-09T00:39:11.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":9386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2016, and February 16, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":30092,"source":{"system":"sec-edgar","filing":"0001127602-19-004920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004920/form4.xml","form_type":"4"}},{"id":411867,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2018-09-19T18:29:02.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":94,"price":63.614,"value":5979.716,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of February 16, 2018 through August, 15 2018. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2018."}],"balance_after":20706,"source":{"system":"sec-edgar","filing":"0001127602-18-028011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218028011/form4.xml","form_type":"4"}},{"id":412712,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2018-08-14T18:05:21.000Z","date":"2018-08-10","kind":"exercise","acquired":false,"shares":1070,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":1070,"derivative":{"underlying":"Common Stock","underlying_shares":1070},"source":{"system":"sec-edgar","filing":"0001127602-18-025255","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218025255/form4.xml","form_type":"4"}},{"id":412711,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15453,"kind":"person","name":"Pletcher Brett A","position":1,"cik":"0001739307","reported_name":"Pletcher Brett A","relationship":{"officer":true,"officer_title":"EVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2018-08-14T18:05:21.000Z","date":"2018-08-10","kind":"tax_withholding","acquired":false,"shares":489,"price":76.73,"value":37520.97,"ownership":{"direct":true},"balance_after":20612,"source":{"system":"sec-edgar","filing":"0001127602-18-025255","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218025255/form4.xml","form_type":"4"}}],"next_cursor":"2018-08-14T18:05:21.000000Z,412711"}